Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase

SUF Rizvi, HL Siddiqui, M Nisar, N Khan… - Bioorganic & medicinal …, 2012 - Elsevier
Vascular endothelial growth factor Receptor-2 (VEGFR-2) kinase inhibition is one of the well
established strategies to promptly tackle tumor growth by suppression of angiogenesis. In …
被引用次数：64 相关文章

[引用][C] Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase

SU FAROOQ RIZVI, H LATIF SIDDIQUI… - Bioorganic & …, 2012 - pascal-francis.inist.fr
Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents
targeting VEGFR-2 tyrosine kinase CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase

SUF Rizvi, HL Siddiqui, M Nisar… - Bioorganic and …, 2012 - espace.library.uq.edu.au
Vascular endothelial growth factor Receptor-2 (VEGFR-2) kinase inhibition is one of the well
established strategies to promptly tackle tumor growth by suppression of angiogenesis. In …

Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase

SUF Rizvi, HL Siddiqui, M Nisar… - Bioorganic & …, 2012 - pubmed.ncbi.nlm.nih.gov
Vascular endothelial growth factor Receptor-2 (VEGFR-2) kinase inhibition is one of the well
established strategies to promptly tackle tumor growth by suppression of angiogenesis. In …

Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase

SUF Rizvi, HL Siddiqui, M Nisar, N Khan… - Bioorganic & Medicinal …, 2012 - infona.pl
Vascular endothelial growth factor Receptor-2 (VEGFR-2) kinase inhibition is one of the well
established strategies to promptly tackle tumor growth by suppression of angiogenesis. In …

Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase.

SU Rizvi, HL Siddiqui, M Nisar, N Khan… - Bioorganic & Medicinal …, 2011 - europepmc.org
Vascular endothelial growth factor Receptor-2 (VEGFR-2) kinase inhibition is one of the well
established strategies to promptly tackle tumor growth by suppression of angiogenesis. In …

Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase

SUF Rizvi, HL Siddiqui, M Nisar, N Khan… - Bioorganic & Medicinal …, 2012 - infona.pl
Vascular endothelial growth factor Receptor-2 (VEGFR-2) kinase inhibition is one of the well
established strategies to promptly tackle tumor growth by suppression of angiogenesis. In …

[引用][C] Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase

SU FAROOQ RIZVI, H LATIF SIDDIQUI… - Bioorganic & medicinal …, 2012 - Elsevier